- Energy Production (providing energy)
- Energy Storage
- Breakdown of fatty acids
- Building Macromolecues
Answer:
The answer is C. BPG aids oxygen delivery to tissues by increasing the affinity of myoglobin for oxygen
Explanation:
The 2,3-bisphosphoglycerate (BPG) which can also be referred to as the 2,3 - di phosphoglycerate , is being produced by the red cells and has the ability to deoxygenate hemoglobin. This is because , his accumulation results to a decrease in the affinity for oxygen, this means that , it will convert hemoglobin to a low oxygen affinity state.
In this case, comparing the options given, it will be concluded that, 2,3 -biphosphoglycerate {BPG} does not aids the delivery of oxygen to tissues, but decreases the affinity of oxygen, which deoxygenate hemoglobin, and causes the concentration of the carbon dioxide to increase.
Answer:
Where are the statements ?
Explanation:
Answer:
Carbon monoxide and antimycin are classified as electron transport inhibitors, FCCP as uncoupling agent, oligomycin as ATP synthase inhibitors, and bongkrekic acid as transport inhibitor.
Explanation:
The electron transport inhibitors refers to the substances, which get combine with distinct constituents of the ETC and prevent the function of the carrier. These substances binds with the carrier and prevent its transformation, which eventually results in halting of the process. The most commonly known electron transport inhibitors are rotenone, carbon monoxide, antimycin, etc.
A molecule that prevents oxidative phosphorylation in mitochondria and prokaryotes, or photo-phosphorylation in cyanobacteria and chloroplasts by inhibiting the production of ATP is known as ATP synthase inhibitors. The most commonly known ATP synthase inhibitor is oligomycin.
Similarly to oligomycin, FCCP or trifluorocarbonylcyanide phenylhydrazone is a potent uncoupler or uncoupling agent that prevents the synthesis of ATP by enhancing membrane proton permeability.
Bongkrekic acid refers to a highly toxic transport inhibitor that prevents the ADP/ATP translocase by combining with the inward facing site of ATP-ADP translocase.
